Unit of Obstetrics and Gynecology, University of Federico II, Naples, Italy (Drs. Di Spiezio Sardo, Zizolfi, and Santangelo).
Department of Obstetrics and Gynecology, ZOL Hospitals, Genk, Belgium (Dr. Campo); European Academy of Gynaecological Surgery, Leuven, Belgium (Drs. Campo, Meier Furst, Di Cesare, and Ombelet).
J Minim Invasive Gynecol. 2020 Mar-Apr;27(3):755-762. doi: 10.1016/j.jmig.2019.05.011. Epub 2019 May 27.
To evaluate the long-term reproductive outcomes in patients with dysmorphic uterus treated by hysteroscopic metroplasty with miniaturized instruments.
Retrospective multicenter cohort study.
Tertiary care university hospitals.
The study was conducted on 214 women with a dysmorphic uterus (T-shaped, infantilis, or other type of dysmorphic uterus according to the European Society of Human Reproduction and Embryology and the European Society for Gynaecological Endoscopy classification system) with history of primary unexplained infertility (group 1) or repeated (>2) early miscarriages (group 2). Dysmorphic uteri were diagnosed by office hysteroscopy and 3-dimensional transvaginal ultrasound (3D-TVS).
All patients underwent in office hysteroscopic metroplasty using a continuous-flow hysteroscope with a 5 Fr operating channel introduced into the uterine cavity using the vaginoscopic approach. Longitudinal incisions were performed on the fibromuscular constriction rings in the isthmic area and in some cases on the other uterine walls with a 5 Fr bipolar electrode or scissors. At the end of the procedure, an antiadhesive gel was applied into the uterine cavity to minimize adhesion formation. Postsurgical assessment of the uterine cavity was carried out through office hysteroscopy and 3D-TVS. All patients were followed for at least 24 months.
The metroplasty was completed in all cases, resulting in a significant increase of uterine cavity volume (100%) and optimization of uterine morphology in 211 of 214 women (98.6%). After 60 months, the overall clinical pregnancy rate was 72.9% (n = 156/214), and the live birth rate was 80.1% (n = 125/156). Specifically, 74 of 156 women (47.4%) conceived spontaneously (with a median time to pregnancy of 5.5 months), of whom 32.4% had previously failed 1 or more attempts at in vitro fertilization/intracytoplasmic sperm injection.
Our long-term follow-up data demonstrate that the hysteroscopic correction of dysmorphic uteri may result in a high live birth rate in women suffering from unexplained infertility or repeated miscarriages.
评估应用微创器械行宫腔镜子宫整形术治疗畸形子宫患者的长期生殖结局。
回顾性多中心队列研究。
三级保健大学医院。
本研究纳入了 214 例畸形子宫(根据欧洲人类生殖与胚胎学会和欧洲妇科内镜学会的分类系统,T 形子宫、幼稚型子宫或其他类型的畸形子宫)患者,这些患者均有原发性不明原因不孕(第 1 组)或反复(>2 次)早期流产(第 2 组)病史。通过门诊宫腔镜和 3 维经阴道超声(3D-TVS)诊断畸形子宫。
所有患者均在门诊接受宫腔镜子宫整形术,使用连续流宫腔镜,经阴道镜入路将 5Fr 操作通道引入子宫腔。在峡部的纤维肌性缩窄环上进行纵向切口,在某些情况下对其他子宫壁进行 5Fr 双极电极或剪刀切口。手术结束时,将防粘连凝胶应用于子宫腔以尽量减少粘连形成。通过门诊宫腔镜和 3D-TVS 对子宫腔进行术后评估。所有患者均随访至少 24 个月。
所有病例均完成了子宫整形术,导致子宫腔容积显著增加(100%),214 例患者中有 211 例(98.6%)子宫形态得到优化。60 个月后,总临床妊娠率为 72.9%(n=156/214),活产率为 80.1%(n=125/156)。具体而言,156 例患者中有 74 例(47.4%)自然妊娠(中位妊娠时间为 5.5 个月),其中 32.4%之前曾有过 1 次或多次体外受精/胞浆内单精子注射失败。
我们的长期随访数据表明,宫腔镜纠正畸形子宫可能会使不明原因不孕或反复流产患者的活产率提高。